Skip to main content

Advertisement

Log in

Optimal surgery for esophagogastric junctional cancer

  • State-of-the-Art Clinical Surgery
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Esophagogastric junctional cancer is classified into three categories according to the Siewert classification, which reflects the epidemiological and biological characteristics. Therapeutic strategies have been evaluated according to the three Siewert types. There is a consensus that types I and III should be treated as esophageal cancer and gastric cancer, respectively. On the other hand, type II is often described as true cardiac cancer, which has different clinicopathological features from the other types. Thus, there is no consensus on the surgical management of type II esophagogastric junctional cancer. The optimal surgical management should focus on the principles of cancer surgery, which take into consideration oncological curability, including an appropriate resection margin, adequate lymphadenectomy, and minimization of postoperative complications. In this review, we evaluate the current relevant literature and evidence, on the surgical treatment of esophagogastric junctional cancer, focusing on type II. Esophagectomy with a thoracic approach has the advantage of ensuring a sufficient proximal resection margin and adequate mediastinal lymphadenectomy. However, the oncological benefit is offset by a high incidence of postoperative complications. Minimally invasive esophagectomy could be a possible solution to reduce complications and improve long-term outcomes. Further development of surgical treatments for Siewert type II is required to improve the outcomes. Furthermore, the surgical team should have expertise in both gastric cancer and esophageal cancer treatment, or patients should be managed with close collaboration between thoracic surgeons and gastric cancer surgeons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Giacopuzzi S, Bencivenga M, Weindelmayer J et al (2017) Western strategy for EGJ carcinoma. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20:60–68

    Article  Google Scholar 

  2. Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459

    Article  CAS  Google Scholar 

  3. McColl KE, Going JJ (2010) Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia. Gut 59:282–284

    Article  Google Scholar 

  4. Leers JM, DeMeester SR, Chan N et al (2009) Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. J Thorac Cardiovasc Surg 138:594–602 (discussion 601 592)

    Article  Google Scholar 

  5. Wong CL, Law S (2019) Extent of lymphadenectomy for Barrett’s cancer. Translational gastroenterology and hepatology 4:36

    Article  Google Scholar 

  6. Zanoni A, Verlato G, Giacopuzzi S et al (2013) Neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal cancer in a single high-volume center. Ann Surg Oncol 20:1993–1999

    Article  CAS  Google Scholar 

  7. Barbour AP, Rizk NP, Gonen M et al (2007) Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 246:1–8

    Article  Google Scholar 

  8. de Manzoni G, Pedrazzani C, Pasini F et al (2002) Results of surgical treatment of adenocarcinoma of the gastric cardia. Ann Thorac Surg 73:1035–1040

    Article  Google Scholar 

  9. Feith M, Stein HJ, Siewert JR (2003) Pattern of lymphatic spread of Barrett’s cancer. World J Surg 27:1052–1057

    Article  Google Scholar 

  10. Pedrazzani C, de Manzoni G, Marrelli D et al (2007) Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg 134:378–385

    Article  Google Scholar 

  11. Grotenhuis BA, Wijnhoven BP, Poley JW et al (2013) Preoperative assessment of tumor location and station-specific lymph node status in patients with adenocarcinoma of the gastroesophageal junction. World J Surg 37:147–155

    Article  Google Scholar 

  12. Cense HA, Sloof GW, Klaase JM et al (2004) Lymphatic drainage routes of the gastric cardia visualized by lymphoscintigraphy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 45:247–252

    Google Scholar 

  13. Feith M, Stein HJ, Siewert JR (2006) Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am 15:751–764

    Article  Google Scholar 

  14. Kakeji Y, Yamamoto M, Ito S et al (2012) Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection. Surg Today 42:351–358

    Article  Google Scholar 

  15. Fujitani K, Miyashiro I, Mikata S et al (2013) Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma of the cardia: results of a multicenter study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 16:301–308

    Article  Google Scholar 

  16. Goto H, Tokunaga M, Sugisawa N et al (2013) Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 16:590–595

    Article  CAS  Google Scholar 

  17. Hasegawa S, Yoshikawa T, Rino Y et al (2013) Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction. Ann Surg Oncol 20:4252–4259

    Article  Google Scholar 

  18. Mine S, Sano T, Hiki N et al (2013) Lymphadenectomy around the left renal vein in Siewert type II adenocarcinoma of the oesophagogastric junction. Br J Surg 100:261–266

    Article  CAS  Google Scholar 

  19. Goto H, Tokunaga M, Miki Y et al (2014) The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 18:375–381

    Article  Google Scholar 

  20. Parry K, Haverkamp L, Bruijnen RC et al (2015) Surgical treatment of adenocarcinomas of the gastro-esophageal junction. Ann Surg Oncol 22:597–603

    Article  CAS  Google Scholar 

  21. Yoshikawa T, Takeuchi H, Hasegawa S et al (2016) Theoretical therapeutic impact of lymph node dissection on adenocarcinoma and squamous cell carcinoma of the esophagogastric junction. Gas Cancer 19:143–149

    Article  CAS  Google Scholar 

  22. Yamashita H, Seto Y, Sano T et al (2017) Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gas Cancer 20:69–83

    Article  CAS  Google Scholar 

  23. Kurokawa Y, Takeuchi H, Doki Y et al (2021) Mapping of lymph node metastasis from esophagogastric junction tumors: a prospective nationwide multicenter study. Ann Surg 274:120–127

    Article  Google Scholar 

  24. Gao F, Chen J, Wang T et al (2014) Incidence of microscopically positive proximal margins in adenocarcinoma of the gastroesophageal junction. PloS one 9:e88010

    Article  Google Scholar 

  25. Mariette C, Castel B, Balon JM et al (2003) Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur J Surg Oncol 29:588–593

    Article  CAS  Google Scholar 

  26. Ito H, Clancy TE, Osteen RT et al (2004) Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg 199:880–886

    Article  Google Scholar 

  27. Mine S, Sano T, Hiki N et al (2013) Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Br J Surg 100:1050–1054

    Article  CAS  Google Scholar 

  28. Siu KF, Cheung HC, Wong J (1986) Shrinkage of the esophagus after resection for carcinoma. Ann Surg 203:173–176

    Article  CAS  Google Scholar 

  29. Hulscher JB, van Sandick JW, de Boer AG et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662–1669

    Article  Google Scholar 

  30. Sasako M, Sano T, Yamamoto S et al (2006) Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 7:644–651

    Article  Google Scholar 

  31. Heger P, Blank S, Gooßen K et al (2019) Thoracoabdominal versus transhiatal surgical approaches for adenocarcinoma of the esophagogastric junction-a systematic review and meta-analysis. Langenbecks Arch Surg 404:103–113

    Article  Google Scholar 

  32. Kinjo Y, Kurita N, Nakamura F et al (2012) Effectiveness of combined thoracoscopic-laparoscopic esophagectomy: comparison of postoperative complications and midterm oncological outcomes in patients with esophageal cancer. Surg Endosc 26:381–390

    Article  Google Scholar 

  33. Sihag S, Wright CD, Wain JC et al (2012) Comparison of perioperative outcomes following open versus minimally invasive Ivor Lewis oesophagectomy at a single, high-volume centre. Eur J Cardiothorac Surg 42:430–437

    Article  Google Scholar 

  34. Ichikawa H, Miyata G, Miyazaki S et al (2013) Esophagectomy using a thoracoscopic approach with an open laparotomic or hand-assisted laparoscopic abdominal stage for esophageal cancer: analysis of survival and prognostic factors in 315 patients. Ann Surg 257:873–885

    Article  Google Scholar 

  35. Lee L, Sudarshan M, Li C et al (2013) Cost-effectiveness of minimally invasive versus open esophagectomy for esophageal cancer. Ann Surg Oncol 20:3732–3739

    Article  Google Scholar 

  36. Meng F, Li Y, Ma H et al (2014) Comparison of outcomes of open and minimally invasive esophagectomy in 183 patients with cancer. J Thorac Dis 6:1218–1224

    PubMed  Google Scholar 

  37. Biere SS, van Berge Henegouwen MI, Maas KW et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet (London, England) 379:1887–1892

    Article  Google Scholar 

  38. Haverkamp L, Seesing MF, Ruurda JP et al (2017) Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer. Dis Esophagus 30:1–7

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Tsutomu Hayashi or Takaki Yoshikawa.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hayashi, T., Yoshikawa, T. Optimal surgery for esophagogastric junctional cancer. Langenbecks Arch Surg 407, 1399–1407 (2022). https://doi.org/10.1007/s00423-021-02375-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-021-02375-7

Keywords

Navigation